Gene Testing

We understand that every cancer is unique and each tumor can vary at the molecular level.

SSPWL after getting you counselled from the best Health care Provider offers a unique US FDA approved genomic profiling through its channel partners which is more than just a test. These tests provide information about clinically relevant biomarkers and genomic alterations to help match patients to approved targeted therapies, immunotherapies, and clinical trials — giving doctors and patients powerful actionable insights for navigating cancer care.

This can help to uncover more treatment possibilities for patients, based on their cancer’s unique genomic profile.

SSPWL can get you accessed to third-generation genomic profiling test

  • FoundationOne®CDx is a comprehensive genomic profile for solid tumors where access to good quality tissue is available.
  • FoundationOne®CDx Liquid its second-generation liquid biopsy test for patients with solid tumors.
  • Foundationone®CDx Heme for patients with hematological cancers or sarcomas.